Availability:

In the U.S. only, the NET-1000 device will be made available to the consumers without making any medical claims of Safety or Efficacy. The NET-1000 and NET-2000 are not the FDA approved devices.

For other Countries, in November of 1999, Auri-Stim Medical Inc. obtained a CE-Marking and approval from the EU (European Union), and the Canadian Ministry of Health for its products. It became an ISO-9002:04, ISO-13485: 96, ISO-13488: 96 certified that allows the company to market the devices in the respective Countries. The NET-1000, NET-2000 devices were labeled as nerve stimulators and classified in Class IIa, low risk medical devices with the intended use for Pain Control and Addictions Therapy.

In the past ten years, the Company had secured approval for the NET-1 device from the Ministries of Health of the following Countries: the Netherlands, the United Kingdom, Switzerland, and Australia. Permissions to export the device to the respective countries were also secured from the FDA. The Company is licensed to market its products in Canada by the Canadian Health ministry, Medical Devices Bureau. In the U.S. the FDA's approval of the NET-1000 device for smoking cessation at best is uncertain.

For further information regarding the availability of the NET-Devices in Canada, and Europe please contact us.

This portfolio is available for Licensing, Joint Venture and Start-Up Investment.

This Technology is available for Licensing and Commercial Partnership. U.S. Patents are pending.